Researchers presented new findings Saturday at a breast-cancer symposium here suggesting that the risks associated with anthracyclines, a class of chemotherapy drugs widely used to treat the disease, outweighed their benefits in some patients.The findings renewed a debate over whether anthracyclines, which have been around since the 1960s, should remain the standard of care in treating breast cancer, or whether newer drugs should be used more frequently instead.
More...
Nearly half of all pregnancies worldwide are unplanned. And despite the many birth control options for...
The Supreme Court on Monday allowed Idaho to begin enforcing a state law barring transgender youth...
Treating gunshot wounds on children was not what Mikael Petrosyan expected when he entered pediatrics.
Petrosyan has...
